Walleye Trading’s Heron Therapeutics HRTX Stock Holding History

Walleye Trading’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,600	Closed	-$112K	–	5068
2022 Q4	$112K	Buy	44,600 +12,063	+37%	+$38.9K	﹤0.01%	3922
2022 Q3	$137K	Buy	+32,537	New	+$127K	﹤0.01%	3923
2021 Q2	–	Sell	-31,308	Closed	-$498K	–	5329
2021 Q1	$508K	Buy	+31,308	New	+$558K	﹤0.01%	2637
2015 Q4	–	Sell	-2,300	Closed	-$56K	–	5437
2015 Q3	$56K	Buy	+2,300	New	+$76.7K	﹤0.01%	3417

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Walleye Trading's HRTX Position: Q1 2023 in Review

Walleye Trading sold out of Heron Therapeutics (HRTX) in Q1 2023, closing a stake of 44,600 shares — an estimated $112K sold.

Walleye Trading first reported a position in HRTX in Q3 2015 and held it in 4 quarters. The position peaked at $508K in Q1 2021. 162 funds tracked by Wall St. Rank hold HRTX as of Q1 2023.

Walleye Trading reported no remaining Heron Therapeutics position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 44,600 Heron Therapeutics shares in Q1 2023, an estimated $112K.
Walleye Trading first reported a position in Heron Therapeutics in Q3 2015 and held it in 4 quarters.
Walleye Trading's Heron Therapeutics position peaked at $508K in Q1 2021.
162 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.